Complications in Breast Surgery

Surgical Clinics of North America

Volumn 87, Issue 2, 2007, Pages 431-451

  Vitug, Angelique F ^a   Newman, Lisa A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BRACHYTHERAPY; BREAST CANCER; BREAST FIBROSIS; BREAST SURGERY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CELLULITIS; CHRONIC PAIN; DIAGNOSTIC IMAGING; HEMATOMA; HUMAN; LYMPH NODE BIOPSY; LYMPHEDEMA; MASTECTOMY; MEDICAL ERROR; MORBIDITY; PARTIAL MASTECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SEROMA; SURGICAL TECHNIQUE; TUMOR BIOPSY; VENOUS THROMBOEMBOLISM; WOUND INFECTION;

BREAST NEOPLASMS; FEMALE; HEMATOMA; HUMANS; LYMPH NODE EXCISION; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; SENTINEL LYMPH NODE BIOPSY; SEROMA; SURGICAL WOUND INFECTION;

EID: 34247897086     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2007.01.005     Document Type: Review

References (94)

1. Grunwald Z., Moore J.H., and Schwartz G.F. Bilateral brachial plexus palsy after a right-side modified radical mastectomy with immediate TRAM flap reconstruction. Breast J 9 1 (2003) 41-43
2. Warner M., Blitt C., Butterworth J., et al. Practice advisory for the prevention of perioperative peripheral neuropathies. A report by the American Society of Anesthesiologists' Task Force on the prevention of perioperative peripheral neuropathies. Anesthesiology 92 (2000) 1168-1182
3. Bejanga B.I. Mondor's disease: analysis of 30 cases. J R Coll Surg Edinb 37 5 (1992) 322-324
4. Catania S., Zurrida S., Veronesi P., et al. Mondor's disease and breast cancer. Cancer 69 9 (1992) 2267-2270
5. Harris A.T. Mondor's disease of the breast can also occur after a sonography-guided core biopsy. AJR Am J Roentgenol 180 1 (2003) 284-285
6. Hou M.F., Huang C.J., Huang Y.S., et al. Mondor's disease in the breast. Kaohsiung J Med Sci 15 11 (1999) 632-639
7. Jaberi M., Willey S.C., and Brem R.F. Stereotactic vacuum-assisted breast biopsy: an unusual cause of Mondor's disease. AJR Am J Roentgenol 179 1 (2002) 185-186
8. Platt R., Zaleznik D.F., Hopkins C.C., et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med 322 3 (1990) 153-160
9. Hoefer R., DuBois J., Ostrow L., et al. Wound complications following modified radical mastectomy: an analysis of perioperative factors. J Am Osteopath Assoc 90 (1990) 47-53
10. Wagman L.D., Tegtmeier B., Beatty J.D., et al. A prospective, randomized double-blind study of the use of antibiotics at the time of mastectomy. Surg Gynecol Obstet 170 1 (1990) 12-16
11. Chen J., Gutkin Z., and Bawnik J. Postoperative infections in breast surgery. J Hosp Infect 17 (1991) 61-65
12. Vinton A.L., Traverso L.W., and Jolly P.C. Wound complications after modified radical mastectomy compared with tylectomy with axillary lymph node dissection. Am J Surg 161 5 (1991) 584-588
13. Platt R., Zucker J.R., Zaleznik D.F., et al. Prophylaxis against wound infection following herniorrhaphy or breast surgery. J Infect Dis 166 3 (1992) 556-560
14. Lipshy K.A., Neifeld J.P., Boyle R.M., et al. Complications of mastectomy and their relationship to biopsy technique. Ann Surg Oncol 3 3 (1996) 290-294
15. Bertin M., Crowe J., and Gordon S. Determinants of surgical site infection after breast surgery. Am J Infect Control 26 (1998) 61-65
16. Thomas R., Alvino P., Cortino G.R., et al. Long-acting versus short-acting cephalosporins for preoperative prophylaxis in breast surgery: a randomized double-blind trial involving 1,766 patients. Chemotherapy 45 3 (1999) 217-223
17. Gupta R., Sinnett D., Carpenter R., et al. Antibiotic prophylaxis for post-operative wound infection in clean elective breast surgery. Eur J Surg Oncol 26 4 (2000) 363-366
18. Nieto A., Lozano M., Moro M.T., et al. Determinants of wound infections after surgery for breast cancer. Zentralbl Gynakol 124 8-9 (2002) 429-433
19. Sorensen L.T., Horby J., Friis E., et al. Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 28 8 (2002) 815-820
20. Witt A., Yavuz D., Walchetseder C., et al. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet Gynecol 101 4 (2003) 745-750
21. Tran C.L., Langer S., Broderick-Villa G., et al. Does reoperation predispose to postoperative wound infection in women undergoing operation for breast cancer?. Am Surg 69 10 (2003) 852-856
22. Platt R., Zucker J.R., Zaleznik D.F., et al. Perioperative antibiotic prophylaxis and wound infection following breast surgery. J Antimicrob Chemother 31 Suppl B (1993) 43-48
23. Pogson C.J., Adwani A., and Ebbs S.R. Seroma following breast cancer surgery. Eur J Surg Oncol 29 9 (2003) 711-717
24. Bonnema J., Ligtensetein D., Wiggers T., et al. The composition of serous fluid after axillary dissection. Eur J Surg 165 (1999) 9-13
25. Giuliano A.E., Haigh P.I., Brennan M.B., et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18 13 (2000) 2553-2559
26. Talbot M.L., and Magarey C.J. Reduced use of drains following axillary lymphadenectomy for breast cancer. ANZ J Surg 72 7 (2002) 488-490
27. Cameron A.E., Ebbs S.R., Wylie F., et al. Suction drainage of the axilla: a prospective randomized trial. Br J Surg 75 12 (1988) 1211
28. Somers R., Jablon L., and Kaplan M. The use of closed suction drainage after lumpectomy and axillary dissection for breast cancer: a prospective randomized trial. Ann Surg 215 (1992) 146-149
29. Flew J. The effect of restriction of shoulder movement. Br J Surg 66 (1979) 302-305
30. Lotz M., Duncan M., Gerber L., et al. Early versus delayed shoulder motion following axillary dissection. Ann Surg 193 (1981) 288-295
31. Schultz I., Barrholm M., and Grondal S. Delayed shoulder exercises in reducing seroma frequency after modified radical mastectomy: a prospective randomized study. Ann Surg Oncol 4 (1997) 293-297
32. Porter K.A., O'Connor S., Rimm E., et al. Electrocautery as a factor in seroma formation following mastectomy. Am J Surg 176 1 (1998) 8-11
33. Keogh G., Doughty J., McArdle C., et al. Seroma formation related to electrocautery in breast surgery-a prospective, randomized trial. Breast 7 (1998) 39-41
34. Classe J., Dupre P., Francois T., et al. Axillary padding as an alternative to closed suction drain for ambulatory axillary lymphadenectomy. Arch Surg 137 (2002) 169-173
35. O'Hea B.J., Ho M.N., and Petrek J.A. External compression dressing versus standard dressing after axillary lymphadenectomy. Am J Surg 177 6 (1999) 450-453
36. Rice D.C., Morris S.M., Sarr M.G., et al. Intraoperative topical tetracycline sclerotherapy following mastectomy: a prospective, randomized trial. J Surg Oncol 73 4 (2000) 224-227
37. Burak Jr. W.E., Goodman P., and Young D. Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin. J Surg Oncol 64 (1997) 27-31
38. Langer S., Guenther J.M., and DiFronzo L.A. Does fibrin sealant reduce drain output and allow earlier removal of drainage catheters in women undergoing operation for breast cancer?. Am Surg 69 1 (2003) 77-81
39. Berger A., Tempfer C., Hartmann B., et al. Sealing of postoperative axillary leakage after axillary lymphadenectomy using a fibrin glue coated collagen patch: a prospective randomised study. Breast Cancer Res Treat 67 1 (2001) 9-14
40. Moore M., Burak Jr. W.E., Nelson E., et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: a randomized prospective clinical trial. J Am Coll Surg 192 5 (2001) 591-599
41. Paterson M.L., Nathanson S.D., and Havstad S. Hematomas following excisional breast biopsies for invasive breast carcinoma: the influence of deep suture approximation of breast parenchyma. Am Surg 60 11 (1994) 845-848
42. Sharma S., Chang D.W., Koutz C., et al. Incidence of hematoma associated with ketorolac after TRAM flap breast reconstruction. Plast Reconstr Surg 107 2 (2001) 352-355
43. Hodges P., and Kam P. The perioperative implications of herbal medicines. Anaesthesia 57 9 (2002) 889-899
44. Ang-Lee M., Moss J., and Yuan C. Herbal medicines and perioperative care. JAMA 286 2 (2001) 208-216
45. Tasmuth T., von Smitten K., and Kalso E. Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer 74 12 (1996) 2024-2031
46. Tasmuth T., Blomqvist C., and Kalso E. Chronic post-treatment symptoms in patients with breast cancer operated in different surgical units. Eur J Surg Oncol 25 (1999) 38-43
47. Stevens P., Dibble S., and Miastowski C. Prevalence, characteristics, and impact of postmastectomy pain syndrome: an investigation of women's experiences. Pain 61 (1995) 61-68
48. Carpenter J., Andrylkowski M., Sloan P., et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 51 (1998) 1285-1292
49. Tasmuth T., von Smitten K., Hietanen P., et al. Pain and other symptoms after different treatment modalities of breast cancer. Ann Oncol 6 (1995) 453-459
50. Bishop S.R., and Warr D. Coping, catastrophizing and chronic pain in breast cancer. J Behav Med 26 3 (2003) 265-281
51. Tasmuth T., Hartel B., and Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain 6 1 (2002) 17-24
52. Rickles F.R., and Edwards R.L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 62 1 (1983) 14-31
53. Duggan C., Marriott K., Edwards R., et al. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer. J Clin Oncol 21 19 (2003) 3588-3593
54. Friis E., Horby J., Sorensen L.T., et al. Thromboembolic prophylaxis as a risk factor for postoperative complications after breast cancer surgery. World J Surg 28 6 (2004) 540-543
55. Andtbacka R.H., Babiera G., Singletary S.E., et al. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 243 1 (2006) 96-101
56. Farrar W.B., and Fanning W.J. Eliminating the dog-ear in modified radical mastectomy. Am J Surg 156 5 (1988) 401-402
57. Chretien-Marquet B., and Bennaceur S. Dog ear: true and false. A simple surgical management. Dermatol Surg 23 7 (1997) 547-550 [discussion: 551]
58. Mirza M., Sinha K.S., and Fortes-Mayer K. Tear-drop incision for mastectomy to avoid dog-ear deformity. Ann R Coll Surg Engl 85 2 (2003) 131
59. Meric F., Buchholz T.A., Mirza N.Q., et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9 6 (2002) 543-549
60. Fehlauer F., Tribius S., Holler U., et al. Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system. Int J Radiat Oncol Biol Phys 55 3 (2003) 651-658
61. LENT-SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31 (1995) 1049-1091
62. Zippel D., Siegelmann-Danieli N., Ayalon S., et al. Delayed breast cellulitis following breast conserving operation. Eur J Surg Oncol 29 4 (2003) 327-330
63. Brewer V.H., Hahn K.A., Rohrbach B.W., et al. Risk factor analysis for breast cellulitis complicating breast conservation therapy. Clin Infect Dis 31 3 (2000) 654-659
64. Staren E.D., Klepac S., Smith A.P., et al. The dilemma of delayed cellulitis after breast conservation therapy. Arch Surg 131 6 (1996) 651-654
65. Rescigno J., McCormick B., Brown A.E., et al. Breast cellulitis after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 29 1 (1994) 163-168
66. Miller S.R., Mondry T., Reed J.S., et al. Delayed cellulitis associated with conservative therapy for breast cancer. J Surg Oncol 67 4 (1998) 242-245
67. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 2 (2003) 289-293
68. Monroe A.T., Feigenberg S.J., and Mendenhall N.P. Angiosarcoma after breast-conserving therapy. Cancer 97 8 (2003) 1832-1840
69. Edeiken S., Russo D.P., Knecht J., et al. Angiosarcoma after tylectomy and radiation therapy for carcinoma of the breast. Cancer 70 3 (1992) 644-647
70. Feigenberg S.J., Mendenhall N.P., Reith J.D., et al. Angiosarcoma after breast-conserving therapy: experience with hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 52 3 (2002) 620-626
71. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15 7 (1997) 2483-2493
72. Liberman L., Goodstone S., and Dershaw D. One operation after percutaneous diagnosis of nonpalpable breast cancer: frequency and associated factors. AJR Am J Roentgenol 178 (2002) 673-679
73. Newman L. Surgical management of high-risk breast lesions. Curr Probl Surg (2004)
74. Petrasek A.J., Semple J.L., and McCready D.R. The surgical and oncologic significance of the axillary arch during axillary lymphadenectomy. Can J Surg 40 1 (1997) 44-47
75. Wright F.C., Walker J., Law C.H., et al. Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol 10 9 (2003) 1054-1058
76. Erickson V.S., Pearson M.L., Ganz P.A., et al. Arm edema in breast cancer patients. J Natl Cancer Inst 93 2 (2001) 96-111
77. Beaulac S.M., McNair L.A., Scott T.E., et al. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg 137 11 (2002) 1253-1257
78. Sener S.F., Winchester D.J., Martz C.H., et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92 4 (2001) 748-752
79. Roses D.F., Brooks A.D., Harris M.N., et al. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg 230 2 (1999) 194-201
80. Grobmyer S.R., Daly J.M., Glotzbach R.E., et al. Role of surgery in the management of postmastectomy extremity angiosarcoma (Stewart-Treves syndrome). J Surg Oncol 73 3 (2000) 182-188
81. Janse A.J., van Coevorden F., Peterse H., et al. Lymphedema-induced lymphangiosarcoma. Eur J Surg Oncol 21 2 (1995) 155-158
82. Stewart F.W., and Treves N. Classics in oncology: lymphangiosarcoma in postmastectomy lymphedema: a report of six cases in elephantiasis chirurgica. CA Cancer J Clin 31 5 (1981) 284-299
83. Moskovitz A.H., Anderson B.O., Yeung R.S., et al. Axillary web syndrome after axillary dissection. Am J Surg 181 5 (2001) 434-439
84. Caluwe G.L., and Christiaens M.R. Chylous leak: a rare complication after axillary lymph node dissection. Acta Chir Belg 103 2 (2003) 217-218
85. Carcoforo P., Soliani G., Maestroni U., et al. Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial. J Am Coll Surg 196 3 (2003) 365-369
86. Krag D.N., Weaver D.L., Alex J.C., et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2 6 (1993) 335-339 [discussion: 340]
87. Giuliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 3 (1994) 391-398 [discussion: 398-401]
88. Leidenius M., Leppanen E., Krogerus L., et al. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 185 2 (2003) 127-130
89. Wilke L.G., McCall L.M., Posther K.E., et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13 4 (2006) 491-500
90. Laurie S.A., Khan D.A., Gruchalla R.S., et al. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol 88 1 (2002) 64-66
91. Efron P., Knudsen E., Hirshorn S., et al. Anaphylactic reaction to isosulfan blue used for sentinel node biopsy: case report and literature review. Breast J 8 6 (2002) 396-399
92. Sadiq T.S., Burns III W.W., Taber D.J., et al. Blue urticaria: a previously unreported adverse event associated with isosulfan blue. Arch Surg 136 12 (2001) 1433-1435
93. Cimmino V.M., Brown A.C., Szocik J.F., et al. Allergic reactions to isosulfan blue during sentinel node biopsy-a common event. Surgery 130 3 (2001) 439-442
94. Mostafa A, Carpenter R. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 2001;27:610.